Mirum Pharmaceuticals Statistics
Total Valuation
MIRM has a market cap or net worth of $6.12 billion. The enterprise value is $6.49 billion.
| Market Cap | 6.12B |
| Enterprise Value | 6.49B |
Important Dates
The last earnings date was Tuesday, November 3, 2026, after market close.
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MIRM has 65.28 million shares outstanding. The number of shares has increased by 21.24% in one year.
| Current Share Class | 65.28M |
| Shares Outstanding | 65.28M |
| Shares Change (YoY) | +21.24% |
| Shares Change (QoQ) | +4.22% |
| Owned by Insiders (%) | 1.33% |
| Owned by Institutions (%) | 100.22% |
| Float | 56.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.12 |
| Forward PS | 7.42 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9.67 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.07
| Current Ratio | 2.07 |
| Quick Ratio | 1.87 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -12.68 |
Financial Efficiency
Return on equity (ROE) is -760.01% and return on invested capital (ROIC) is -13.95%.
| Return on Equity (ROE) | -760.01% |
| Return on Assets (ROA) | -10.01% |
| Return on Invested Capital (ROIC) | -13.95% |
| Return on Capital Employed (ROCE) | -19.51% |
| Weighted Average Cost of Capital (WACC) | 7.55% |
| Revenue Per Employee | $1.43M |
| Profits Per Employee | -$1.92M |
| Employee Count | 470 |
| Asset Turnover | 0.74 |
| Inventory Turnover | 4.95 |
Taxes
In the past 12 months, MIRM has paid $3.47 million in taxes.
| Income Tax | 3.47M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +33.71% in the last 52 weeks. The beta is 0.74, so MIRM's price volatility has been lower than the market average.
| Beta (5Y) | 0.74 |
| 52-Week Price Change | +33.71% |
| 50-Day Moving Average | 89.29 |
| 200-Day Moving Average | 98.53 |
| Relative Strength Index (RSI) | 60.94 |
| Average Volume (20 Days) | 681,206 |
Short Selling Information
The latest short interest is 6.66 million, so 10.21% of the outstanding shares have been sold short.
| Short Interest | 6.66M |
| Short Previous Month | 6.99M |
| Short % of Shares Out | 10.21% |
| Short % of Float | 11.74% |
| Short Ratio (days to cover) | 7.16 |
Income Statement
In the last 12 months, MIRM had revenue of $670.78 million and -$903.88 million in losses. Loss per share was -$15.12.
| Revenue | 670.78M |
| Gross Profit | 548.19M |
| Operating Income | -145.08M |
| Pretax Income | -900.41M |
| Net Income | -903.88M |
| EBITDA | -118.31M |
| EBIT | -145.08M |
| Loss Per Share | -$15.12 |
Balance Sheet
The company has $373.69 million in cash and $743.56 million in debt, with a net cash position of -$369.88 million or -$5.67 per share.
| Cash & Cash Equivalents | 373.69M |
| Total Debt | 743.56M |
| Net Cash | -369.88M |
| Net Cash Per Share | -$5.67 |
| Equity (Book Value) | -54.19M |
| Book Value Per Share | -0.83 |
| Working Capital | 303.55M |
Cash Flow
In the last 12 months, operating cash flow was -$271.26 million and capital expenditures -$2.59 million, giving a free cash flow of -$273.85 million.
| Operating Cash Flow | -271.26M |
| Capital Expenditures | -2.59M |
| Depreciation & Amortization | 26.77M |
| Net Borrowing | 135.97M |
| Free Cash Flow | -273.85M |
| FCF Per Share | -$4.19 |
Margins
Gross margin is 81.72%, with operating and profit margins of -21.63% and -134.75%.
| Gross Margin | 81.72% |
| Operating Margin | -21.63% |
| Pretax Margin | -134.23% |
| Profit Margin | -134.75% |
| EBITDA Margin | -17.64% |
| EBIT Margin | -21.63% |
| FCF Margin | n/a |
Dividends & Yields
MIRM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -21.24% |
| Shareholder Yield | -21.24% |
| Earnings Yield | -16.13% |
| FCF Yield | -4.48% |
Analyst Forecast
The average price target for MIRM is $155.00, which is 65.39% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $155.00 |
| Price Target Difference | 65.39% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (3Y) | 30.39% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MIRM has an Altman Z-Score of 1.44 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.44 |
| Piotroski F-Score | 3 |